Checkup and management of upper urinary tract tumours in 2010: An update from the committee of cancer from the French National Association of Urology;Bilan et prise en charge d'une tumeur de la voie excrétrice urinaire supérieure en 2010 : mise au point du comité de cancérologie de l'Association francaise d'urologie

Progres en Urologie

Volumn 20, Issue 4, 2010, Pages 260-271

  Roupret M ^a   Wallerand, H ^a   Traxer, O ^a   Roy, C ^a   Mazerolles, C ^a   Saint, F ^a   Quintens, H ^a   Amsellem Ouazana, D ^a   Bernardini, S ^a   Guy, L ^a   Soulie M ^a   Pfister, C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Microsatellite instability; Nephroureterectomy; Prognosis; Renal pelvis; Ureter; Ureteroscopy; Urothelial carcinoma

Indexed keywords

HUMAN; KIDNEY PELVIS; KIDNEY TUMOR; SHORT SURVEY; URETER TUMOR;

HUMANS; KIDNEY NEOPLASMS; KIDNEY PELVIS; URETERAL NEOPLASMS;

EID: 77950340152     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.purol.2010.01.008     Document Type: Short Survey

References (67)

1. Irani J., Bernardini S., Bonnal J.L., Chauvet B., Colombel M., Davin J.L., et al. Tumeurs urothéliales. Prog Urol 17 (2007) 1065-1098
2. Jemal A., Siegel R., Ward E., Hao Y., Xu J., and Thun M.J. Cancer statistics. CA Cancer J Clin 59 (2009) 225-249
3. Hall M.C., Womack S., Sagalowsky A.I., Carmody T., Erickstad M.D., and Roehrborn C.G. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 52 (1998) 594-601
4. Kirkali Z., Chan T., Manoharan M., Algaba F., Busch C., Cheng L., et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 66 (2005) 4-34
5. Catto J.W., Yates D.R., Rehman I., Azzouzi A.R., Patterson J., Sibony M., et al. Behavior of urothelial carcinoma with respect to anatomical location. J Urol 177 (2007) 1715-1720
6. Izquierdo L., Mengual L., Gazquez C., Ingelmo-Torres M., and Alcaraz A. Molecular characterization of upper urinary tract tumours. BJU Int (2009) 10.1111/j.1464-410X.2009.09135.x
7. Roupret M., Catto J., Coulet F., Azzouzi A.R., Amira N., Karmouni T., et al. Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma. J Med Genet 41 (2004) e91
8. Park S., Hong B., Kim C.S., and Ahn H. The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract. J Urol 171 (2004) 621-625
9. van der Poel H.G., Antonini N., van Tinteren H., and Horenblas S. Upper urinary tract cancer: location is correlated with prognosis. Eur Urol 48 (2005) 438-444
10. Azemar M.D., Comperat E., Richard F., Cussenot O., and Roupret M. Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: Frequency, risk factors, and surveillance. Urol Oncol (2009) 10.1016/j.urolonc.2009.06.003
11. Sanderson K.M., and Roupret M. Upper urinary tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: an update on the risk factors, surveillance regimens and treatments. BJU Int 100 (2007) 11-16
12. Shariat S.F., Sfakianos J.P., Droller M.J., Karakiewicz P.I., Meryn S., and Bochner B.H. The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int (2009) 10.1111/j.1464-410X.2009.09072.x
13. Grollman A.P., Shibutani S., Moriya M., Miller F., Wu L., Moll U., et al. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc Natl Acad Sci U S A 104 (2007) 12129-12134
14. Colin P., Koenig P., Ouzzane A., Berthon N., Villers A., Biserte J., et al. Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int 104 (2009) 1436-1440
15. Dragicevic D., Djokic M., Pekmezovic T., Micic S., Hadzi-Djokic J., Vuksanovic A., et al. Survival of patients with transitional cell carcinoma of the ureter and renal pelvis in Balkan endemic nephropathy and non-endemic areas of Serbia. BJU Int 99 (2007) 1357-1362
16. Nortier J.L., Martinez M.C., Schmeiser H.H., Arlt V.M., Bieler C.A., Petein M., et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 342 (2000) 1686-1692
17. Roupret M., Cancel-Tassin G., Comperat E., Fromont G., Sibony M., Molinie V., et al. Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinoma. Cancer Epidemiol Biomarkers Prev 16 (2007) 2500-2503
18. Langner C., Hutterer G., Chromecki T., Rehak P., and Zigeuner R. Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract. Virchows Arch 448 (2006) 604-611
19. Langner C., Hutterer G., Chromecki T., Winkelmayer I., Rehak P., and Zigeuner R. pT classification, grade, and vascular invasion as prognostic indicators in urothelial carcinoma of the upper urinary tract. Mod Pathol 19 (2006) 272-279
20. Olgac S., Mazumdar M., Dalbagni G., and Reuter V.E. Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases. Am J Surg Pathol 28 (2004) 1545-1552
21. Lopez-Beltran A., and Montironi R. Non-invasive urothelial neoplasms: according to the most recent WHO classification. Eur Urol 46 (2004) 170-176
22. Wang L.J., Wong Y.C., Huang C.C., Wu C.H., Hung S.C., and Chen H.W. Multidetector computerized tomography urography is more accurate than excretory urography for diagnosing transitional cell carcinoma of the upper urinary tract in adults with hematuria. J Urol 183 (2010) 48-55
23. Wang L.J., Wong Y.C., Chuang C.K., Huang C.C., and Pang S.T. Diagnostic accuracy of transitional cell carcinoma on multidetector computerized tomography urography in patients with gross hematuria. J Urol 181 (2009) 524-531 [discussion 531]
24. Chlapoutakis K., Theocharopoulos N., Yarmenitis S., and Damilakis J. Performance of computed tomographic urography in diagnosis of upper urinary tract urothelial carcinoma, in patients presenting with hematuria: systematic review and meta-analysis. Eur J Radiol (2008) 10.1016/j.ejrad.2008.10.026
25. Keeley F.X., Kulp D.A., Bibbo M., McCue P.A., and Bagley D.H. Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol 157 (1997) 33-37
26. Cornu JN, Roupret M, Carpentier X, Geavlete B, Diez de Medina SG, Cussenot O, et al. Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma. World J urol 2010 (in press).
27. Pasqui F., Dubosq F., Tchala K., Tligui M., Gattegno B., Thibault P., et al. Impact on active scope deflection and irrigation flow of all endoscopic working tools during flexible ureteroscopy. Eur Urol 45 (2004) 58-64
28. Natalin R.A., and Landman J. Where next for the endoscope?. Nat Rev Urol 6 (2009) 622-628
29. Andonian S., Okeke Z., and Smith A.D. Digital ureteroscopy: the next step. J Endourol 22 (2008) 603-606
30. Stern J.M., Yiee J., and Park S. Safety and efficacy of ureteral access sheaths. J Endourol 21 (2007) 119-123
31. Sowter S.J., Ilie C.P., Efthimiou I., and Tolley D.A. Endourologic management of patients with upper-tract transitional-cell carcinoma: long-term follow-up in a single center. J Endourol 21 (2007) 1005-1009
32. Margulis V., Shariat S.F., Matin S.F., Kamat A.M., Zigeuner R., Kikuchi E., et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 115 (2009) 1224-1233
33. Lehmann J., Suttmann H., Albers P., Volkmer B., Gschwend J.E., Fechner G., et al. Surgery for metastatic urothelial carcinoma with curative intent: the German experience (AUO AB 30/05). Eur Urol 55 (2009) 1293-1299
34. Roscigno M., Shariat S.F., Margulis V., Karakiewicz P., Remzi M., Kikuchi E., et al. The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed?. Eur Urol 56 (2009) 512-518
35. Zigeuner R., Shariat S.F., Margulis V., Karakiewicz P.I., Roscigno M., Weizer A., et al. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol (2009) 10.1016/j.eururo.2009.11.035
36. Fromont G., Roupret M., Amira N., Sibony M., Vallancien G., Validire P., et al. Tissue microarray analysis of the prognostic value of E-cadherin Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma. Eur Urol 48 (2005) 764-770
37. Eltz S., Comperat E., Cussenot O., and Roupret M. Molecular and histological markers in urothelial carcinomas of the upper urinary tract. BJU Int 102 (2008) 532-535
38. Roupret M., Fromont G., Azzouzi A.R., Catto J.W., Vallancien G., Hamdy F.C., et al. Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma. Urology 65 (2005) 1233-1237
39. Roupret M., Azzouzi A.R., and Cussenot O. Microsatellite instability and transitional cell carcinoma of the upper urinary tract. BJU Int 96 (2005) 489-492
40. Oosterlinck W., Solsona E., van der Meijden A.P., Sylvester R., Bohle A., Rintala E., et al. EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol 46 (2004) 147-154
41. Capitanio U., Shariat S.F., Isbarn H., Weizer A., Remzi M., Roscigno M., et al. Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. Eur Urol 56 (2009) 1-9
42. Rassweiler J.J., Schulze M., Marrero R., Frede T., Palou Redorta J., and Bassi P. Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: is it better than open surgery?. Eur Urol 46 (2004) 690-697
43. Roupret M., Hupertan V., Traxer O., Loison G., Chartier-Kastler E., Conort P., et al. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. Urology 67 (2006) 1181-1187
44. Roupret M., Smyth G., Irani J., Guy L., Davin J.L., Saint F., et al. Oncological risk of laparoscopic surgery in urothelial carcinomas. World J urol 27 (2009) 81-88
45. Hsueh T.Y., Huang Y.H., Chiu A.W., Huan S.K., and Lee Y.H. Survival analysis in patients with upper urinary tract transitional cell carcinoma: a comparison between open and hand-assisted laparoscopic nephroureterectomy. BJU Int 99 (2007) 632-636
46. Roupret M., Hupertan V., Sanderson K.M., Harmon J.D., Cathelineau X., Barret E., et al. Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience. Urology 69 (2007) 656-661
47. Waldert M., Remzi M., Klingler H.C., Mueller L., and Marberger M. The oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer are equal to those of open nephroureterectomy. BJU Int 103 (2009) 66-70
48. Matin S.F., and Gill I.S. Recurrence and survival following laparoscopic radical nephroureterectomy with various forms of bladder cuff control. J Urol 173 (2005) 395-400
49. Herr H.W., Bochner B.H., Dalbagni G., Donat S.M., Reuter V.E., and Bajorin D.F. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167 (2002) 1295-1298
50. Koppie T.M., Vickers A.J., Vora K., Dalbagni G., and Bochner B.H. Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed?. Cancer 107 (2006) 2368-2374
51. Liedberg F., and Mansson W. Lymph node metastasis in bladder cancer. Eur Urol 49 (2006) 13-21
52. Brausi M.A., Gavioli M., De Luca G., Verrini G., Peracchia G., Simonini G., et al. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival. Eur Urol 52 (2007) 1414-1418
53. Chen G.L., and Bagley D.H. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. J Urol 164 (2000) 1173-1176
54. Elliott D.S., Blute M.L., Patterson D.E., Bergstralh E.J., and Segura J.W. Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma. Urology 47 (1996) 819-825
55. Elliott D.S., Segura J.W., Lightner D., Patterson D.E., and Blute M.L. Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. Urology 58 (2001) 174-178
56. Johnson G.B., Fraiman M., and Grasso M. Broadening experience with the retrograde endoscopic management of upper urinary tract urothelial malignancies. BJU Int 95 Suppl. 2 (2005) 110-113
57. Keeley Jr. F.X., Bibbo M., and Bagley D.H. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma. J Urol 157 (1997) 1560-1565
58. Traxer O., Dubosq F., Jamali K., Gattegno B., and Thibault P. New-generation flexible ureterorenoscopes are more durable than previous ones. Urology 68 (2006) 276-279 [discussion 280-1]
59. Daneshmand S., Quek M.L., and Huffman J.L. Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience. Cancer 98 (2003) 55-60
60. Deligne E., Colombel M., Badet L., Taniere P., Rouviere O., Dubernard J.M., et al. Conservative management of upper urinary tract tumors. Eur Urol 42 (2002) 43-48
61. Iborra I., Solsona E., Casanova J., Ricos J.V., Rubio J., and Climent M.A. Conservative elective treatment of upper urinary tract tumors: a multivariate analysis of prognostic factors for recurrence and progression. J Urol 169 (2003) 82-85
62. Lam J.S., and Gupta M. Ureteroscopic management of upper tract transitional cell carcinoma. Urol Clin North Am 31 (2004) 115-128
63. Roupret M., Traxer O., Tligui M., Conort P., Chartier-Kastler E., Richard F., et al. Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection. Eur Urol 51 (2007) 709-713 [discussion 714]
64. Humphreys M.R., Miller N.L., Williams Jr. J.C., Evan A.P., Munch L.C., and Lingeman J.E. A new world revealed: early experience with digital ureteroscopy. J Urol 179 (2008) 970-975
65. Palou J., Piovesan L.F., Huguet J., Salvador J., Vicente J., and Villavicencio H. Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup. J Urol 172 (2004) 66-69
66. Grossman H.B., Natale R.B., Tangen C.M., Speights V.O., Vogelzang N.J., Trump D.L., et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349 (2003) 859-866
67. Chen G.L., El-Gabry E.A., and Bagley D.H. Surveillance of upper urinary tract transitional cell carcinoma: the role of ureteroscopy, retrograde pyelography, cytology and urinalysis. J Urol 164 (2000) 1901-1904